Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma.
Goedegebuure RSA, Harrasser M, de Klerk LK, van Schooten TS, van Grieken NCT, Eken M, Grifhorst MS, Pocorni N, Jordanova ES, van Berge Henegouwen MI, Pouw RE, Verheul HMW, van der Vliet JJ, van Laarhoven HWM, Thijssen VLJL, Bass AJ, De Gruijl TD, Derks S. Goedegebuure RSA, et al. Oncoimmunology. 2021 Aug 4;10(1):1954807. doi: 10.1080/2162402X.2021.1954807. eCollection 2021. Oncoimmunology. 2021. PMID: 34377591 Free PMC article.
Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies.
de Klerk LK, Goedegebuure RSA, van Grieken NCT, van Sandick JW, Cats A, Stiekema J, van der Kaaij RT, Farina Sarasqueta A, van Engeland M, Jacobs MAJM, van Wanrooij RLJ, van der Peet DL, Thorner AR, Verheul HMW, Thijssen VLJL, Bass AJ, Derks S. de Klerk LK, et al. Among authors: goedegebuure rsa. Mol Oncol. 2021 Apr;15(4):901-914. doi: 10.1002/1878-0261.12907. Epub 2021 Feb 23. Mol Oncol. 2021. PMID: 33506581 Free PMC article.
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation.
Goedegebuure RSA, Kleibeuker EA, Buffa FM, Castricum KCM, Haider S, Schulkens IA, Ten Kroode L, van den Berg J, Jacobs MAJM, van Berkel AM, van Grieken NCT, Derks S, Slotman BJ, Verheul HMW, Harris AL, Thijssen VL. Goedegebuure RSA, et al. J Exp Clin Cancer Res. 2021 May 8;40(1):161. doi: 10.1186/s13046-021-01962-2. J Exp Clin Cancer Res. 2021. PMID: 33964942 Free PMC article.
Combining Radiation Therapy With Interferons: Back to the Future.
Goedegebuure RSA, Vonk C, Kooij LP, Derks S, Thijssen VLJL. Goedegebuure RSA, et al. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):56-69. doi: 10.1016/j.ijrobp.2020.02.016. Epub 2020 Feb 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32068114 Review.
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.
Huijts CM, Werter IM, Lougheed SM, Goedegebuure RS, van Herpen CM, Hamberg P, Tascilar M, Haanen JB, Verheul HM, de Gruijl TD, van der Vliet HJ; Dutch WIN-O Consortium. Huijts CM, et al. Cancer Immunol Immunother. 2019 Feb;68(2):319-329. doi: 10.1007/s00262-018-2248-3. Epub 2018 Nov 9. Cancer Immunol Immunother. 2019. PMID: 30413837 Free PMC article. Clinical Trial.
Development of transient radioresistance during fractionated irradiation in vitro.
van den Berg J, Castricum KCM, Meel MH, Goedegebuure RSA, Lagerwaard FJ, Slotman BJ, Hulleman E, Thijssen VLJL. van den Berg J, et al. Among authors: goedegebuure rsa. Radiother Oncol. 2020 Jul;148:107-114. doi: 10.1016/j.radonc.2020.04.014. Epub 2020 Apr 17. Radiother Oncol. 2020. PMID: 32344261
[Non-metastatic oesophageal cancer: diagnosis and treatment].
Voeten DM, den Bakker CM, Goedegebuure RSA, Heineman DJ, Daams F, van der Peet DL. Voeten DM, et al. Among authors: goedegebuure rsa. Ned Tijdschr Geneeskd. 2019 Sep 13;163:D3718. Ned Tijdschr Geneeskd. 2019. PMID: 31556490 Dutch.
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS, Harrasser M, Seidel J, Bos EN, Fleitas T, van Mourik M, Pouw RE, Goedegebuure RSA, Doeve BH, Sanders J, Bos J, van Berge Henegouwen MI, Thijssen VLJL, van Grieken NCT, van Laarhoven HWM, de Gruijl TD, Derks S. Groen-van Schooten TS, et al. Among authors: goedegebuure rsa. Front Immunol. 2024 Apr 4;15:1372272. doi: 10.3389/fimmu.2024.1372272. eCollection 2024. Front Immunol. 2024. PMID: 38638445 Free PMC article.
11 results